Trump tariffs will loom over financial markets in 2025 but may not be as nasty as the president-elect previously flagged.

Dual-listed regenerative medicine company Avita Medical has seen its share price slide ~19% today on a downgrade of its ...

The ASX keeps charging, while Wall Street slips on strong US data and Energy Transition Minerals pops on Trump's Greenland ...

Australian Mines (ASX:AUZ) is exploring potential production scenarios after nearly doubling its scandium resource in NSW.

Aubiotech hopes to score some quick runs with a pre-budget submission on ways to fix the sector's "stubborn issues" ...

After the benchmark S&P/ASX 200 surged 7.5 per cent in 2024, investors are looking to see where the growth will come from in ...

The advent of a Trump presidency is accelerating a divergence on digital currencies between the world’s two largest economies ...

Cell therapies have suffered from hyped-up expectations, clinical setbacks and high costs. But maybe, just maybe, Arovella is ...

ASX tech rocked a 50pc gain in 2024, Archer Materials shone in December, and Dubber and Brainchip cashed in on major ...

ASX 200 edges up on a tech rally, while miners struggle, Barrick Gold threatens a Mali shutdown, and Bitcoin bounces back.

Kalamazoo Resources led materials sector gainers this morning as the release of drill assays from its Mallina West gold ...

Opyl has entered a joint venture with X Firm to market its TrialKey platform in key markets, while Dimerix has inked another ...